Osteomalacia. Diagnóstico y tratamiento
Keywords:
osteomalacia, falta de mineralización, sustancia osteoide, diagnóstico, tratamientoAbstract
Introducción: la osteomalacia se caracteriza por la falta de mineralización de la sustancia osteoide, que afecta al hueso cortical y al hueso esponjoso maduro. Es una enfermedad que se presenta en adultos y niños, aunque la causa es diferente en cada uno.
Objetivo: exponer la generalidad de la osteomalacia por ser una enfermedad que produce serias afectaciones a la población que la padece, especialmente a los niños. Se enfatiza en el diagnóstico y su tratamiento.
Desarrollo: a fin de resumir los elementos esenciales para establecer el diagnóstico de osteomalacia hay que plantear en primer lugar, la presencia de un trastorno de la mineralización ósea, de ahí que además de tener en cuenta las causas de la enfermedad, su curso clínico y la sintomatología.
Conclusiones: una recomendación importante es no tener en cuenta la posibilidad de complicaciones en el curso de la enfermedad, como las fracturas, que, aunque sean parte del cuadro clínico, al producirse pueden ocasionar graves problemas, como el caso de las que aparecen en las costillas, que si se desplazan pueden interesar órganos vitales, de modo que en este tipo de pacientes no debe excluirse la posibilidad de emergencias o de urgencias reumatológicas tanto en los adultos como en los niños.
Downloads
References
Kraenzlin M. Ostéomalacie. Forum Med Suisse 2003;32:754-63.
Peris P. Osteomalacia. En: Farreras P, Rozman C, editores. Farreras-Rozman. Medicina interna. 16.a ed. Madrid: Elsevier; 2009. pp. 1085-8.
Bonilla Hernán M G. Osteomalacia. En: Arboleya Rodriguez L, Pérez Edo L, directores. Manual de Enfermedades Óseas (SER). 2ª ed. Madrid: Médica Panamericana. 2010. pp. 381-87.
Peris P. Diagnóstico y tratamiento de la osteomalacia por el reumatólogo. Reumatol Clin. 2011;7(S2):S22-S27.
Doreen G. Le calcium santé des dents. Station de recherche Agroscope Liebefeld-Posieux ALP. Berne:2009.
Perris P. Diagnóstico y tratamiento de la osteomalacia por el reumatólogo. Reumatol Clin. 2011;7(S2):S22-S27.
Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S, Meunier PJ . Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med. 1992;327(23):1637-42.
Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 supplementation on fractures and mortality in men and women living in the community: randomized double blind controlled trial. BMJ. 2003;326:469.
Lamy O, Aubry-Rozier B, Stoll D. Therapeutic goal of vitamin D: optimal serum level and dose requirements. Rev Med Suisse. 2012;8:2066-71.
Ruiz-Esquide V, Peris P, Gifre L, Guañabens N. Alteraciones del metabolismo óseo en la cirugía bariátrica. Med Clin (Barc). 2011;136:215-21.
Stoll D, So A, Krieg MA, Aubry-Rozier B. High prevalence of hypovitaminosis D in a Swiss rheumatology outpatient population. Swiss Med Wkly. 2011;141(2122).
Gallagher JC1, Sai A, Templin T 2nd, Smith L. Dose response to vitamin D supplementation in postmenopausal women: a randomized trial. Ann Intern Med 2012; 156:425-37.
Laroche M. Failure of teriparatide in treatment of bone complications of adult hypophosphatasia. Calcif Tissue Int. 2012;90(3):250.
Bhadada SK, Dhiman V, Mukherjee S, Aggarwal S, Bal A, Sukumar SP, Van Hul W. Fibrogenesis Imperfect Ossium and Response to Human Growth Hormone: A Potential Therapy. J Clin Endocrinol Metab 2017;102:1750-56.
Arturi A, Arturi V, Giacomone D. Emergencias y urgencias en Reumatología clínica. Revista Argentina de Reumatología 2017;28(4):35-41.
Published
How to Cite
Issue
Section
License
Warning of rights of author
The authors that publish in this journal agree with the following terms:
The authors conserve the rights of author and concede to the journal the right of the first publication, fulfilling with the license Creative Commons Attribution License that allows to others share the work with recognition of the authorship of their articles, and the initial publication in this journal.
The authors can establish separately additional agreements for the no exclusive distribution of the version of the work published in the journal (for example, situate it in an institutional repository, in a personal blog or publish it partial or totally in a book), with a recognition of their initial publication in this journal.
To be able to send the manuscript or part of him passed three months of published, for his evaluation to other publishers, identifying it or not with the same title; whenever allusion is made to our journale and know it the new publisher.
The publishing committee of the Cuban Journal of Rheumatology authorizes to other publishers, to reproduce the articles published in our magazine, whenever it indicate the origin of the same.
The authors should send a document in Office Word application format through the electronic address of the magazine with a similar format to that we include next:
---------------------------------------------------------------------------------------------------------------------
Statement of authorship and cede of articles for the publication of the scientific work in the Cuban Journal of Rheumatology
Date:
Those who subscribe certify that are the authors of the work:
Of this form communicate the originality of our article clearing that the concepts and knowledges of other authors that have included in the text of the article, have been quoted properly in the bibliography.
We do proof besides that the article in question is original and has not been published, total neither partially, in another journal.
To be approved for his publication in the Cuban Journal of Rheumatology, do secession of the rights of publication to the same one through the method that realizes it usually.
In front of any catchword that exist by the article that send to evaluate, relieve of of the responsibility to the Cuban Journal of Rheumatology holding us responsible with all the difficulties that can berelated by any situation.
We include to continuation the name and the signature of all authors and collaborators of this article.
Name: Signature:
